In the present study, for the first time, we evaluated the histological features of ST of RA patients enrolled at different disease phases (i.e. naive to treatment, inadequately responder to conventional DMARDs and at the time of stable clinical and US remission after MTX + TNF-i combined therapy) stratified according to the BMI category. This evidence concerns the gene TNF and rheumatoid arthritis.